In this recent webinar hosted by Roche Diagnostics Asia Pacific, Dr Bharathi Vennapusa, a pathologist working with the Medical & Scientific Affairs field team at Roche Diagnostics USA, discusses the overarching points to consider when it comes to commercially available IHC tests. She emphasises the importance of lab quality management systems and how FDA approvals and guidelines come into play. Highlighting the common pain points that many laboratories face with such processes, she provides resources to further demonstrate how these guidelines work.